545 Tumor-specific cytolytic CD4 T cells mediate protective immunity against human cancer
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Journal for ImmunoTherapy of Cancer - 8(2020), Suppl 3 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pedro Romero [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
|---|
| doi: |
10.1136/jitc-2020-SITC2020.0545 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ052842363 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ052842363 | ||
| 003 | DE-627 | ||
| 005 | 20230503064853.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/jitc-2020-SITC2020.0545 |2 doi | |
| 035 | |a (DE-627)DOAJ052842363 | ||
| 035 | |a (DE-599)DOAJ621e6071c8b84e4cbd3945d9072e8bba | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC254-282 | |
| 100 | 0 | |a Pedro Romero |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 545 Tumor-specific cytolytic CD4 T cells mediate protective immunity against human cancer |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 653 | 0 | |a Neoplasms. Tumors. Oncology. Including cancer and carcinogens | |
| 700 | 0 | |a George Coukos |e verfasserin |4 aut | |
| 700 | 0 | |a David Gfeller |e verfasserin |4 aut | |
| 700 | 0 | |a Camilla Jandus |e verfasserin |4 aut | |
| 700 | 0 | |a Maria Pia Protti |e verfasserin |4 aut | |
| 700 | 0 | |a Alexandre Harari |e verfasserin |4 aut | |
| 700 | 0 | |a Julien Schmidt |e verfasserin |4 aut | |
| 700 | 0 | |a Philippe Guillaume |e verfasserin |4 aut | |
| 700 | 0 | |a Amélie Cachot |e verfasserin |4 aut | |
| 700 | 0 | |a Margaux Saillard |e verfasserin |4 aut | |
| 700 | 0 | |a Mariia Bilous |e verfasserin |4 aut | |
| 700 | 0 | |a Yen-Cheng Liu |e verfasserin |4 aut | |
| 700 | 0 | |a Xiaokang Li |e verfasserin |4 aut | |
| 700 | 0 | |a Alexander Rockinger |e verfasserin |4 aut | |
| 700 | 0 | |a Tania Wyss |e verfasserin |4 aut | |
| 700 | 0 | |a Raphael Genolet |e verfasserin |4 aut | |
| 700 | 0 | |a Walter Reith |e verfasserin |4 aut | |
| 700 | 0 | |a Laurence De Leval |e verfasserin |4 aut | |
| 700 | 0 | |a Kalliopi Ioannidou |e verfasserin |4 aut | |
| 700 | 0 | |a Daniel Speiser |e verfasserin |4 aut | |
| 700 | 0 | |a Alexander Mathis |e verfasserin |4 aut | |
| 700 | 0 | |a Hatice Altug |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal for ImmunoTherapy of Cancer |d BMJ Publishing Group, 2013 |g 8(2020), Suppl 3 |w (DE-627)DOAJ000014281 |x 20511426 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2020 |g number:Suppl 3 |
| 856 | 4 | 0 | |u https://doi.org/10.1136/jitc-2020-SITC2020.0545 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/621e6071c8b84e4cbd3945d9072e8bba |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2051-1426 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2020 |e Suppl 3 | ||